 
	
	
 
							
					
		
Please try another search
 
            
        
    Updates with India open, earnings context Investing.com-- Most Asian stocks advanced on Monday, with Japanese shares hitting record highs amid renewed bets that fiscal dove Sanae Takaichi will secure...
Esperion Therapeutics (ESPR) announced it reached a settlement agreement with Dr. Reddy’s Laboratories to resolve patent litigation over generic versions of cholesterol medications NEXLETOL and...
Investing.com-- Asian pharmaceutical stocks fell on Friday after U.S. President Donald Trump announced a 100% tariff on the sector, although bigger losses were limited by the president offering some...
Investing.com - H.C. Wainwright has reiterated its Buy rating and $18.00 price target on Coya Therapeutics (NASDAQ:COYA), representing a significant upside from the current price of $5.47, following...
Investing.com -- Deutsche Bank struck a more upbeat tone on European pharmaceuticals, upgrading Alvotech to Buy from Hold while keeping its price target at $14. Shares in Alvotech rose 4.6% in U.S....
Investing.com-- Asian pharmaceutical stocks fell on Tuesday as investors digested a warning from U.S. President Donald Trump on links between autism and vaccines and the taking of popular pain...
Investing.com - Lucid Capital Markets has reiterated its Buy rating and $20.00 price target on Coya Therapeutics (NASDAQ:COYA), representing a potential 257% upside from the current price of $5.60,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review 
	 
	 
	 
	 
	 
	 
	